No Cover Image

Journal article 202 views 39 downloads

Ero1α-Dependent ERp44 Dissociation From RyR2 Contributes to Cardiac Arrhythmia

Shanna Hamilton Orcid Logo, Radmila Terentyeva, Vladimir Bogdanov, Tae Yun Kim Orcid Logo, Fruzsina Perger, Jiajie Yan, Xun Ai Orcid Logo, Cynthia A. Carnes, Andriy E. Belevych, Christopher George Orcid Logo, Jonathan P. Davis, Sandor Gyorke, Bum-Rak Choi Orcid Logo, Dmitry Terentyev Orcid Logo

Circulation Research, Volume: 130, Issue: 5, Pages: 711 - 724

Swansea University Author: Christopher George Orcid Logo

  • 59209.pdf

    PDF | Version of Record

    © 2022 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License

    Download (8.16MB)

Abstract

Background:Oxidative stress in cardiac disease promotes proarrhythmic disturbances in Ca2+ homeostasis, impairing luminal Ca2+ regulation of the sarcoplasmic reticulum (SR) Ca2+ release channel, the RyR2 (ryanodine receptor), and increasing channel activity. However, exact mechanisms underlying redo...

Full description

Published in: Circulation Research
ISSN: 0009-7330 1524-4571
Published: Ovid Technologies (Wolters Kluwer Health) 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa59209
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: Background:Oxidative stress in cardiac disease promotes proarrhythmic disturbances in Ca2+ homeostasis, impairing luminal Ca2+ regulation of the sarcoplasmic reticulum (SR) Ca2+ release channel, the RyR2 (ryanodine receptor), and increasing channel activity. However, exact mechanisms underlying redox-mediated increase of RyR2 function in cardiac disease remain elusive. We tested whether the oxidoreductase family of proteins that dynamically regulate the oxidative environment within the SR are involved in this process.Methods:A rat model of hypertrophy induced by thoracic aortic banding (TAB) was used for ex vivo whole heart optical mapping and for Ca2+ and reactive oxygen species imaging in isolated ventricular myocytes (VMs).Results:The SR-targeted reactive oxygen species biosensor ERroGFP showed increased intra-SR oxidation in TAB VMs that was associated with increased expression of oxidoreductase Ero1α. Pharmacological (EN460) or genetic Ero1α inhibition normalized SR redox state, increased Ca2+ transient amplitude and SR Ca2+ content, and reduced proarrhythmic spontaneous Ca2+ waves in TAB VMs under β-adrenergic stimulation (isoproterenol). Ero1α overexpression in Sham VMs had opposite effects. Ero1α inhibition attenuated Ca2+-dependent ventricular tachyarrhythmias in TAB hearts challenged with isoproterenol. Experiments in TAB VMs and human embryonic kidney 293 cells expressing human RyR2 revealed that an Ero1α-mediated increase in SR Ca2+-channel activity involves dissociation of intraluminal protein ERp44 from the RyR2 complex. Site-directed mutagenesis and molecular dynamics simulations demonstrated a novel redox-sensitive association of ERp44 with RyR2 mediated by intraluminal cysteine 4806. ERp44-RyR2 association in TAB VMs was restored by Ero1α inhibition, but not by reducing agent dithiothreitol, as hypo-oxidation precludes formation of covalent bond between RyR2 and ERp44.Conclusions:A novel axis of intraluminal interaction between RyR2, ERp44, and Ero1α has been identified. Ero1α inhibition exhibits promising therapeutic potential by stabilizing RyR2-ERp44 complex, thereby reducing spontaneous Ca2+ release and Ca2+-dependent tachyarrhythmias in hypertrophic hearts, without causing hypo-oxidative stress in the SR.
Keywords: cardiovascular disease; constriction; heart failure; homeostasis; oxidoreductase
College: Faculty of Medicine, Health and Life Sciences
Funders: This work was supported by The Ohio State University President’s Postdoc-toral Scholars Award (S. Hamilton), National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) K99HL155492 (S. Hamilton), NIH NIAAA R01AA024769 and NIH NHLBI RO1HL146744 (X. Ai), British Heart Foundation RG/15/6/31436 (C.H. George), NIH NHLBI R01HL132213 (J.P. Davis), NIH NHLBI R01HL063043 (S. Gyorke), NIH NHLBI R01HL074045 (S. Gyorke and J.P. Davis), NIH NHLBI R01HL142588, and NIH NHLBI HL121796 (D. Terentyev).
Issue: 5
Start Page: 711
End Page: 724